4.6 Article Proceedings Paper

Dopamine dysfunction in AD/HD: integrating clinical and basic neuroscience research

Journal

BEHAVIOURAL BRAIN RESEARCH
Volume 130, Issue 1-2, Pages 65-71

Publisher

ELSEVIER
DOI: 10.1016/S0166-4328(01)00431-4

Keywords

attention-deficit hyperactivity disorder (ADHD); dopamine; methylphenidate; amphetamine; autoreceptors; prefrontal cortex; prefrontal-striatal-thalamic cortical circuit; striatum; attention; impulsivity; MRI; fMRI; PET; dopamine transporter (DAT); rate dependency

Ask authors/readers for more resources

There is strong evidence that the catecholamines dopamine and norepinephrine are both important in the pathophysiology of ADHD, as well as in the mechanism of therapeutic action of stimulant drugs. Due to the known effects of stimulants in blocking reuptake of catecholamines and (in the case Of D-amphetamine) facilitating their release, it has traditionally been believed that the stimulants compensate for catecholamine deficiency in ADHD. More recently, however, alternate hypotheses of a hyperdopaminergic and/or hyper-noradrenergic state in ADHD have been suggested. This paper will be limited to a review of the evidence for involvement of dopamine in mediating behavioral and cognitive symptoms and response to stimulants in ADHD, with implications for possible mechanisms, (C) 2002 Elsevier Science B.V. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available